<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Healthcare Access Inequities &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/healthcare-access-inequities/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 20 Jan 2026 06:03:12 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Healthcare Access Inequities &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Socioeconomic Factors Influence Melanoma Survival Rates</title>
		<link>https://bioengineer.org/socioeconomic-factors-influence-melanoma-survival-rates/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 20 Jan 2026 06:02:43 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Early detection barriers in melanoma]]></category>
		<category><![CDATA[eğitim ve sağlık hizmetlerine]]></category>
		<category><![CDATA[gelir]]></category>
		<category><![CDATA[Geographic access to melanoma care]]></category>
		<category><![CDATA[Health equity in cancer care** **Açıklama:** 1. **Socioeconomic disparities in melanoma survival:** Makalenin ana odağı]]></category>
		<category><![CDATA[Healthcare Access Inequities]]></category>
		<category><![CDATA[Makale içeriğine ve ana temalara göre en uygun 5 etiket: **Socioeconomic disparities in melanoma survival]]></category>
		<category><![CDATA[melanoma survival disparities]]></category>
		<category><![CDATA[Racial disparities in melanoma outcomes]]></category>
		<category><![CDATA[racial disparities in melanoma prognosis]]></category>
		<category><![CDATA[sociodemographic cancer outcomes]]></category>
		<category><![CDATA[socioeconomic determinants of health]]></category>
		<guid isPermaLink="false">https://bioengineer.org/socioeconomic-factors-influence-melanoma-survival-rates/</guid>

					<description><![CDATA[In recent years, the increasing incidence of melanoma has captured the attention of researchers, healthcare professionals, and the general public alike. This skin cancer, characterized by the uncontrolled growth of pigment-producing cells known as melanocytes, has profound implications for patient survival rates and health care systems globally. Emerging studies have underscored not just the biological [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">318758</post-id>	</item>
		<item>
		<title>Racial, economic barriers hinder access to medicine for treating opioid use disorder</title>
		<link>https://bioengineer.org/racial-economic-barriers-hinder-access-to-medicine-for-treating-opioid-use-disorder/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Thu, 15 Aug 2024 00:08:53 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Buprenorphine Dispensing]]></category>
		<category><![CDATA[Economic Barriers]]></category>
		<category><![CDATA[Healthcare Access Inequities]]></category>
		<category><![CDATA[Opioid Use Disorder]]></category>
		<category><![CDATA[Racial Segregation]]></category>
		<guid isPermaLink="false">https://bioengineer.org/racial-economic-barriers-hinder-access-to-medicine-for-treating-opioid-use-disorder/</guid>

					<description><![CDATA[PORTLAND, Ore. – Patients with a prescription for an opioid use disorder medication may have a tough time getting it filled if their pharmacy is in a community that’s racially and economically segregated, according to a new study led by scientists at Oregon State University and Johns Hopkins University. PORTLAND, Ore. – Patients with a [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">231564</post-id>	</item>
	</channel>
</rss>
